Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study
In children with XLH treated with burosumab, HC was an infrequent side effect and preexisting NC did not worsen.
Authors
- Ravit Regev (ORCID: https://orcid.org/0000-0002-0846-733X)
- Ori Goldberg (ORCID: https://orcid.org/0009-0002-6725-8017)
- Avivit Brener (ORCID: https://orcid.org/0000-0002-2742-8264)
- Yael Levy‐Shraga (ORCID: https://orcid.org/0000-0002-8603-4230)
- Mika Shapira Rootman (ORCID: https://orcid.org/0000-0002-6758-7673)
- Yael Lebenthal (ORCID: https://orcid.org/0000-0001-5963-0574)
- Dov Tiosano (ORCID: https://orcid.org/0000-0002-9992-235X)
- Roxana Cleper (ORCID: https://orcid.org/0000-0003-2721-5004)
- Rachel Bello
- Yael Borovitz (ORCID: https://orcid.org/0000-0001-6708-629X)
- Daniel Landau (ORCID: https://orcid.org/0000-0001-6347-7891)
- Leonid Zeitlin
- Miriam Davidovits
- Adi Chezana
- Shelly Levi (ORCID: https://orcid.org/0000-0003-0244-0301)
- Shoshana Gal
Institutions
- Ben-Gurion University of the Negev (IL)
- Tel Aviv University (IL)
- Hebrew University of Jerusalem (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Sheba Medical Center (IL)
- Rambam Health Care Campus (IL)
- Schneider Children's Medical Center (IL)
- Edmond and Lily Safra Children's Hospital (IL)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2024-12-02
- DOI
- https://doi.org/10.3389/fped.2024.1487890
- Citations
- 4
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.36